According to the technical analyst from Anand Rathi, Linde India can rally to Rs 3,875; while Saregama can surge to Rs 425.
On the upside, Gold futures need to break and sustain above Rs 55,230 in order to negate the likely corrective move. Meanwhile, Silver futures seem on course to test Rs 72,000.
The derivative analyst from HDFC Securities recommends to Buy Bharat Forge 880 Call and simultaneously Sell 900 Call for the January expiry.
According to the technical analyst from Anand Rathi, Metro Brands can rally to Rs 910; while Bayer Cropscience can surge to Rs 5,200.
Analysts expect the Indian equity markets to consolidate over the next few months, as they fully digest the negatives of rich valuations, rising interest rates amid growth headwinds.
CLOSING BELL: The S&P BSE Sensex gained 732 points from the day's low, while the Nifty 50 jumped 218 points in intra-day trades, partly on account of short-covering owing to the monthly F&O expiry.
On the downside, key support for MCX Crude Oil stands at Rs 6,350, below which a steeper fall to Rs 4,800 seems possible. Rs 413 - 418 is the resistance zone for Natural Gas on Wednesday.
Among individual stocks, the technical & derivative analyst from HDFC Securities recommends buying RCF and NCC.
CLOSING BELL: The BSE Metal index surged over 4.5 per cent amid reports of China further relaxing its zero Covid policy.
The stellar performance of sugar stocks began in 2021, and is likely to continue in the new year - 2023, indicates the technical charts.
However, the overall market wide position dipped below Rs 2.20 lakh crore for the first time in the last six months.
According to the technical analyst from Anand Rathi, ABB can advance to Rs 2,880; while MRPL can jump to Rs 57.
CLOSING BELL: The NSE Nifty shut shop at 18,015, up 208 points. Broader indices outperformed the benchmarks with gains of up to 3 per cent.
Indigo and SpiceJet shares must surpass these key hurdles to embark on a new trend.
On the upside, Gold futures are likely to counter some resistance around Rs 55,150, Silver around Rs 70,250.
Market at close: The pain was even more severe in the broader market space where the BSE MidCap and SmallCap indices fell 3 and 4 per cent, respectively
Technically, the Nifty Pharma index needs to immediate hurdle at 13,500, for further upside to 14,250.
The options data indicates that the Nifty may look to hold on the 18,000-mark till expiry, given the high OI at the 18,000 Put.
The derivative analyst from HDFC Securities recommends to Buy Federal Bank 128 Put and simultaneously Sell 125 Put for the December expiry.
CLOSING BELL: The Pharma index advanced over 2 per cent today as diagnostics and healthcare firms climbed amid rising Covid-19 cases globally